Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

Novel bis-acridine antitumor agents discovered by Italian university researchers

March 17, 1999

Chinese scientists design antitumor podophyllotoxin derivatives with high selectivity

March 16, 1999

New patent issues covering Cytoclonal's novel methods of producing paclitaxel

March 15, 1999

New DAG analogues acting as PKC agonists or antagonists

March 15, 1999

Warner-Lambert prepares irreversible tyrosine kinase inhibitors

March 12, 1999

U.K. is country of first launch for Schering-Plough's oral alkylating agent

March 12, 1999

ImClone receives milestone payment for C225 clinical advance

March 12, 1999

Amgen and Praecis to develop and commercialize abarelix

March 12, 1999

New U.S. patent broadens the base of ImmunoGen's TAP technology

March 12, 1999

Techniclone enters licensing agreement for Oncolym with Schering AG

March 12, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 8, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
GDE4 blockade promotes remyelination, study finds
BioWorld Science
Myelin is crucial for the correct functioning of nerve signaling and its loss is a feature of neurological disorders. The cells responsible for myelination in the...